Hanmi Pharm. Co., Ltd. (KRX:128940)
462,000
+40,000 (9.48%)
Nov 20, 2026, 1:05 PM KST
Hanmi Pharm. Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Hanmi Pharm. stock has a consensus rating of "Buy" and an average price target of ₩636,364. The average 1-year stock price forecast is 37.74% higher than the current stock price, while the lowest is ₩560,000 (+21.21%) and the highest is ₩730,000 (+58.01%).
Price Target: ₩636,364 (+37.74%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Hanmi Pharm. stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 5 | 5 | 5 |
| Buy | 7 | 6 | 5 | 6 | 6 | 6 |
| Hold | 1 | 0 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 12 | 12 | 11 | 11 | 11 |
Financial Forecast
Revenue This Year
1.44T
from 1.55T
Decreased by -7.17%
Revenue Next Year
1.73T
from 1.44T
Increased by 20.11%
EPS This Year
20.54K
from 13.36K
Increased by 53.75%
EPS Next Year
15.72K
from 20.54K
Decreased by -23.47%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.